Literature DB >> 23332235

Rheumatoid arthritis: still a chronic disease.

Pierre Miossec1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23332235     DOI: 10.1016/S0140-6736(12)62192-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

1.  The immunoglobulin D Fc receptor expressed on fibroblast-like synoviocytes from patients with rheumatoid arthritis contributes to the cell activation.

Authors:  Yu-Jing Wu; Wen-Sheng Chen; Heng-Shi Chen; Xing Dai; Jin Dong; Ying Wang; Ling-Ling Zhang; Yan Chang; Qiong Huang; Xiao-Yi Jia; Wei Wei
Journal:  Acta Pharmacol Sin       Date:  2017-08-03       Impact factor: 6.150

2.  Knockdown of sphingosine kinase 1 inhibits the migration and invasion of human rheumatoid arthritis fibroblast-like synoviocytes by down-regulating the PI3K/AKT activation and MMP-2/9 production in vitro.

Authors:  Hongxia Yuan; Pingting Yang; Dun Zhou; Wei Gao; Zhenyu Qiu; Fang Fang; Shuang Ding; Weiguo Xiao
Journal:  Mol Biol Rep       Date:  2014-05-10       Impact factor: 2.316

3.  Interleukin-21 induces migration and invasion of fibroblast-like synoviocytes from patients with rheumatoid arthritis.

Authors:  R Xing; Y Jin; L Sun; L Yang; C Li; Z Li; X Liu; J Zhao
Journal:  Clin Exp Immunol       Date:  2016-02-15       Impact factor: 4.330

Review 4.  Management of rheumatoid arthritis in People's Republic of China - focus on tocilizumab and patient considerations.

Authors:  Geng Wang; Rong Mu; Huji Xu
Journal:  Int J Gen Med       Date:  2015-05-12

5.  Role of cysteine‑rich angiogenic inducer 61 in fibroblast‑like synovial cell proliferation and invasion in rheumatoid arthritis.

Authors:  Li-Gang Jie; Run-Yue Huang; Wei-Feng Sun; Song Wei; Yong-Liang Chu; Qing-Chun Huang; Hong-Yan Du
Journal:  Mol Med Rep       Date:  2014-10-27       Impact factor: 2.952

6.  Protective effect of low dose intra-articular cadmium on inflammation and joint destruction in arthritis.

Authors:  Paola Bonaventura; Guillaume Courbon; Aline Lamboux; Fabien Lavocat; Hubert Marotte; Francis Albarède; Pierre Miossec
Journal:  Sci Rep       Date:  2017-05-25       Impact factor: 4.379

7.  The Bone-Protecting Efficiency of Chinese Medicines Compared With Western Medicines in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Comparative Studies.

Authors:  Xiao Cai; Xiu-Min Chen; Xuan Xia; Kun Bao; Rong-Rong Wang; Jian-Hong Peng; Hai-Jun Liu; Qiao-Wen Yang; Jing-Yao Yan; Mao-Jie Wang; Hua Yu; Jin-Jian Lu; Yuan-Jia Hu; Per-Johan Jakobsson; Ze-Huai Wen; Run-Yue Huang; Qing-Chun Huang
Journal:  Front Pharmacol       Date:  2018-08-30       Impact factor: 5.810

8.  Rheumatoid vasculitis: going, going, but not yet gone.

Authors:  David S Pisetsky
Journal:  Arthritis Res Ther       Date:  2015-05-08       Impact factor: 5.156

9.  Introduction: ‘Why is there persistent disease despite aggressive therapy of rheumatoid arthritis?’.

Authors:  Pierre Miossec
Journal:  Arthritis Res Ther       Date:  2014       Impact factor: 5.156

10.  Protective effect of Asarum extract in rats with adjuvant arthritis.

Authors:  Wenqiang Zhang; Juan Zhang; Ming Zhang; Lin Nie
Journal:  Exp Ther Med       Date:  2014-08-29       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.